###begin article-title 0
###xml 24 29 24 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NBS1 </italic>
Association between the NBS1 E185Q polymorphism and cancer risk: a meta-analysis
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 199 204 199 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NBS1 </italic>
###xml 213 222 213 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Glu185Gln</italic>
NBS1 is a key DNA repair protein in the homologous recombination repair pathway and a signal modifier in the intra-S phase checkpoint that plays important roles in maintaining genomic stability. The NBS1 8360G>C (Glu185Gln) is one of the most commonly studied polymorphisms of the gene for their association with risk of cancers, but the results are conflicting.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 197 202 197 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NBS1 </italic>
###xml 115 123 <span type="species:ncbi:9606">patients</span>
We performed a meta-analysis using 16 eligible case-control studies (including 17 data sets) with a total of 9,734 patients and 10,325 controls to summarize the data on the association between the NBS1 8360G>C (E185Q) polymorphism and cancer risk.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 156 158 156 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 304 307 304 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs </italic>
###xml 355 357 355 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 402 405 402 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs </italic>
###xml 445 447 445 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 719 721 719 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
Compared with the common 8360GG genotype, the carriers of variant genotypes (i.e., 8360 GC/CC) had a 1.06-fold elevated risk of cancer (95% CI = 1.00-1.12, P = 0.05) in a dominant genetic model as estimated in a fixed effect model. However, the association was not found in an additive genetic model (CC vs GG) (odds ratio, OR = 0.98, 95% CI = 0.85-1.13, P = 0.78) nor in a recessive genetic model (CC vs GC +GG) (OR = 0.94, 95% CI = 0.82-1.07, P = 0.36). The effect of the 8360G>C (E185Q) polymorphism was further evaluated in stratification analysis. It was demonstrated that the increased risk of cancer associated with 8360G>C variant genotypes was more pronounced in the Caucasians (OR = 1.07, 95% CI = 1.01-1.14, P = 0.03).
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 36 41 36 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NBS1 </italic>
###xml 71 76 71 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GC/CC</italic>
Our meta-analysis suggests that the NBS1 E185Q variant genotypes (8360 GC/CC) might be associated with an increased risk of cancer, especially in Caucasians.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 199 200 199 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 355 356 355 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 595 596 595 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 848 849 848 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 894 895 894 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 896 897 896 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 1000 1001 1000 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1105 1106 1105 1106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1107 1108 1107 1108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 225 230 <span type="species:ncbi:9606">human</span>
###xml 555 560 <span type="species:ncbi:9606">human</span>
###xml 958 966 <span type="species:ncbi:9606">patients</span>
DNA damage may increase cancer risk, and DNA double-strand breaks (DSBs) cause the most potentially serious damage to the genome. If unrepaired, DSBs may lead to genomic instability and thus cancer [1]. The repair of DSBs in human cells includes two different pathways, homologous recombination repair (HR) and non-homologous end joining (NHEJ) pathways [2]. The initial step in both pathways is the recognition and signaling of DNA DSBs by a protein complex containing Nijmegen breakage syndrome 1 (NBS1), meiotic recombination 11 homologue (MRE11), and human RAD50 homologue (RAD50) proteins [3]. NBS1 plays an important role as a sensor in repairing the DSBs and activates the cell-cycle checkpoint signaling; it also directly binds to the phosphorylated histone H2AX that is located around DSBs, participating in maintaining genomic stability [4], and prevents cells from telomeric fusion [2,5]. A markedly impaired DSB repair was observed in cells from patients with Nijmegen breakage syndrome [6], in which cells are characteristic of chromosome instability and sensitivity to DSB-causative agents [7,8].
###end p 11
###begin p 12
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NBS1 </italic>
###xml 114 115 114 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 116 118 116 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 126 131 126 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NBS1 </italic>
###xml 361 363 361 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 364 366 364 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 525 527 525 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 528 530 528 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 976 985 976 985 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Glu185Gln</italic>
###xml 1185 1186 1185 1186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 1187 1189 1187 1189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1190 1192 1190 1192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1334 1339 1334 1339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NBS1 </italic>
###xml 28 33 <span type="species:ncbi:9606">human</span>
The NBS1 gene is located on human chromosome 8q21 and codes for a protein termed nibrin (754-amino acid protein) [9-11]. Some NBS1 mutations and polymorphisms have been reported to be associated with risk of several cancers, including cancers of the breast, lung, bladder, ovaries, non-Hodgkin lymphoma, malignant melanoma and basal cell carcinoma of the skin [12-18]. A homozygous 5-bp deletion in exon 6 (657del5) has been reported to be associated with an elevated risk of breast cancer in Polish and Russian populations [15,19]. However, the 657del5 variant appears to be a Slavic origin with a low frequency of approximate 0.5% in Eastern Europe populations and even lower in other ethnic groups. According to the Environmental Genome Project (EGP) SNP database of the (NIEHS) (, accessed on March 1, 2008), 249 single nucleotide polymorphisms (SNPs) are reported, of which 84 are common polymorphisms (with a minor allele frequency > 5%). Among these SNPs, the 8360G>C (Glu185Gln, E185Q, rs1805794) is one of the most commonly studied polymorphisms. However, the results of studies on association between the 8360G>C (E185Q) polymorphism and the risk of cancers are conflicting [1,20,21]. To summarize the published data, we performed a meta-analysis from all eligible case-control studies to assess the association between the NBS1 E185Q polymorphism and cancer risk.
###end p 12
###begin title 13
Methods
###end title 13
###begin title 14
Bioinformatics Analysis
###end title 14
###begin p 15
###xml 48 53 48 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NBS1 </italic>
###xml 142 143 142 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 143 145 143 145 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 418 420 418 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
Based on the resequencing information about the NBS1 gene provided by the NIEHS Environmental Genome Project , we calculated the D' value and r2 coefficient by linkage disequilibrium (LD) analysis. In addition, we further analyzed SNPs in LD with 8360G>C in a 5-Mb region on chromosome 8 via the HapMap SNP database (release #36, , March 1, 2008) that have genotypes for the CEPH trios with the ssSNPer web interface [22].
###end p 15
###begin title 16
Literature search strategy for identification of the studies
###end title 16
###begin p 17
###xml 209 214 209 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NBS1 </italic>
We carried out a literature search in the PubMed and SciFinder Scholar (CA web version) database (between January 2000 and February 2008) to identify all articles that investigated the association between the NBS1 E185Q polymorphism and cancer risk in all ethnic groups, using the following keywords and subject terms: 'NBS1,' 'cancer,' and 'polymorphism.' We evaluated the titles and abstracts of all relevant publications first but excluded abstracts, case reports, editorials, and review articles. Studies included in the current meta-analysis had to meet the following criteria: (a) The study used a case-control study design; (b) the report described cancer diagnoses and the sources of cases and controls; (c) the report had available genotype frequency; (d) the authors offered the size of the samples, odds ratios (ORs) and their 95% confidence intervals (CIs); (e) the definition of the exposure or risk genotypes was similar in all reports; and (f) the methods of data collection and analysis were statistically acceptable.
###end p 17
###begin title 18
Data extraction
###end title 18
###begin p 19
###xml 27 32 27 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NBS1 </italic>
Data were collected on the NBS1 E185Q genotype for studies of different types of cancers. The first author, a year of publication, country, ethnicity of the study population, and the number of cases and controls and allele frequency were also described.
###end p 19
###begin title 20
Methods for quantitative synthesis
###end title 20
###begin p 21
###xml 32 33 32 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 33 35 33 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 38 41 38 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pq </italic>
###xml 43 44 43 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">q</italic>
###xml 44 46 44 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 57 59 57 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 102 104 102 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">q </italic>
###xml 110 111 110 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 523 528 523 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NBS1 </italic>
###xml 596 599 596 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs </italic>
###xml 617 620 617 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs </italic>
###xml 643 646 643 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs </italic>
###xml 735 737 735 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 742 745 742 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#967;</italic>
###xml 745 746 743 744 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 827 829 825 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 839 841 837 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1061 1063 1057 1059 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1292 1294 1288 1290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1483 1484 1479 1480 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Z</italic>
###xml 1500 1501 1496 1497 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
The Hardy-Weinberg equilibrium (p2 + 2pq + q2 = 1, where p is the frequency of the variant allele and q = 1 - p), was tested by goodness-of-fit Chi-square tests to compare the observed genotype frequencies with expected genotype frequencies in cancer-free controls for all studies. The selections of published studies used for meta-analysis were further evaluated in sensitivity analyses. Odds ratio (OR) and 95% confident interval (CI) in each case-control study was used to assess the strength of association between the NBS1 8360G>C (E185Q) genotypes and the risk of cancer in dominant (GC+CC vs GG), additive (CC vs GG), and recessive (CC vs GC +GG) genetic models. The combined OR was calculated according to the method of Woolf [23]. A chi2-based Q statistic test was performed to assess the between-study heterogeneity [24]. If the P value of heterogeneity test was >/= 0.10, a fixed effect model using the Mantel-Haenszel method was used to calculate the combined OR, which assumed the same homogeneity of the effect size across all the studies. If the P value of the heterogeneity test was <0.10, it showed that the heterogeneity between-study was statistically significant. The random effects model using the DerSimonian and Laird method was performed to calculate the combined OR [25]. If there was no between-study heterogeneity, the results from those two methods calculating the combined OR would be identical. The significance of the combined OR was determined by the Z-test, in which P< 0.05 was considered significant. Finally, combined ORs and their 95% CIs were presented. Stratification analyses for different types of cancers were conducted for breast cancer, lung cancer, bladder cancer, basal cell carcinoma, and other cancers (i.e., ovarian, prostate, or colorectal cancer) to estimate cancer-specific OR. Stratification analyses by ethnicity were also conducted for Caucasian, Asian and African Americans populations to estimate ethnic-specific ORs.
###end p 21
###begin p 22
###xml 248 250 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 317 318 317 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 354 355 354 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Publication bias was assessed with the funnel plot, in which the standard error of log (OR) of each study was plotted against its OR value. An asymmetric plot suggested possible publication bias by the method of the Egger's linear regression test [26]. The significance of the intercept was determined by the Student t-test as suggested by Egger. If the P-value of Egger's linear regression test was less than 0.05, it meant that there was publication bias in the meta-analysis.
###end p 22
###begin p 23
###xml 350 351 350 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
The SAS/Genetics software program (Version 9.1, SAS Institute, Inc., Cary, NC, USA) was used to determine the LD of SNP pairs and Hardy-Weinberg equilibrium. Other statistical software used included SPSS12.0 for windows software (SPSS Inc., Chicago, USA), software Stata version 7.0, and Review Manager (version 4.2, the Cochrane Collaboration). All P-values were two-sided.
###end p 23
###begin title 24
Results
###end title 24
###begin title 25
Literature search and meta-analysis databases
###end title 25
###begin p 26
###xml 55 59 55 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NBS1</italic>
###xml 260 262 260 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 263 265 263 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 363 365 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 366 368 366 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 369 371 369 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 432 434 432 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 578 579 578 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 580 582 580 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 583 585 583 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 586 588 586 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 589 591 589 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 592 594 592 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 595 597 595 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 598 600 598 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 745 746 745 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 896 901 896 901 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NSB1 </italic>
###xml 974 975 974 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 976 978 976 978 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 979 981 979 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 982 984 982 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 985 987 985 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 1017 1019 1017 1019 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1020 1022 1020 1022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 1023 1025 1023 1025 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 1058 1060 1058 1060 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1061 1063 1061 1063 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 1064 1066 1064 1066 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 1103 1105 1103 1105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1106 1108 1106 1108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 1132 1134 1132 1134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1162 1164 1162 1164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 1198 1200 1198 1200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
We found 31 epidemiologic studies using the search by 'NBS1,' 'cancer' and 'polymorphism' through Pubmed and SciFinder Scholar (CA web version). Of these 31 studies, 15 studies were excluded, 9 studies were excluded because they were not case-control studies [27-35], 5 studies were excluded because E185Q polymorphism or its genotype frequency was not reported [14,36-39], and one studies focused on hematotoxicity but not cancer [40]. The remaining 16 case-control studies included 17 data sets (because Millian's study included two populations: African-American and whites) [1,13,16-18,20,21,41-49]. All the articles used DNA from blood samples for genotyping. We established a database for the extracted information from each article. Table 1 shows the essential information, including first author, cancer type, year of the publication, the numbers of cases and controls, and frequencies of NSB1 8360 C allele for all studies. There were six studies for breast cancer [1,20,21,41,42], three for the lung cancer [18,43,44], three for the bladder cancer [16,45,48], two for the basal cell carcinoma [17,46], one for the ovarian [13], one for prostate cancer [47], and one for colorectal cancer [49]. Among 17 eligible datasets included in the final analysis, there were 14 (82.3%) of Caucasians, two (11.8%) of Chinese, and one (5.9%) of African-Americans. Additional information is listed in the forest plots in our meta-analyses.
###end p 26
###begin p 27
Summary of eligible studies considered in the meta-analysis
###end p 27
###begin p 28
*: United Kingdom SEARCH study. Danish MALOVA study. United States FROC study. United Kingdom Royal Marsden Hospital and young ovarian cancer study (UK RMH/YOV).
###end p 28
###begin p 29
###xml 0 12 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#167;</sup>
section sign: Subjects including population and hospital source.
###end p 29
###begin p 30
###xml 128 130 128 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 168 171 168 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#967;</italic>
###xml 171 173 169 171 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 181 183 179 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 376 377 374 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
The frequency distributions of genotypes in control groups from all studies were in accordance with Hardy-Weinberg equilibrium (P > 0.05), except for Hebbring's study (chi2 = 3.93, P = 0.05). We performed a sensitivity analysis to for the selection of published studies in the meta-analysis. The frequencies of the 8360 C allele in the control groups are also listed in Table 1. Compared with the reported frequency from the database of HapMap , the frequencies of 8360 C allele in the meta-analysis were not as similar as that from the International HapMap Project. There might be population diversity. We would take that into account in the meta-analysis.
###end p 30
###begin title 31
Test for heterogeneity
###end title 31
###begin p 32
###xml 6 7 6 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 65 68 65 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs </italic>
###xml 105 107 105 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 167 169 167 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 256 258 256 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 295 297 295 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 405 406 405 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 411 412 411 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 532 534 532 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 570 572 570 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 611 613 611 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 656 658 656 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 725 727 725 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 775 777 775 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 822 824 822 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
Table 2 shows that no between-study heterogeneity was found in C vs G allele comparison for 16 datasets (P = 0.10) and in dominant genetic models for all 17 datasets (P = 0.54). However, there was between-study heterogeneity in the additive genetic model (P = 0.02) and recessive genetic model (P = 0.03) for 16 datasets. In the subgroup analyses by the type of cancers and ethnicity, as shown in Figures 1 and 2, the heterogeneity test did not show any significant difference in dominant genetic models: three lung cancer studies (P = 0.10), six breast cancer studies (P = 0.27), three bladder cancer studies (P = 0.86), two basal cell carcinoma studies (P = 0.42), other cancers (ovarian, prostate, and colorectal cancer) (P = 0.74), fourteen Caucasian population studies (P = 0.64), and two Chinese population studies (P = 0.14).
###end p 32
###begin p 33
Summary of ORs for various comparisons
###end p 33
###begin p 34
###xml 28 31 28 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs </italic>
###xml 63 66 63 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs </italic>
###xml 108 111 108 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs </italic>
*Additive genetic model: CC vs GG, recessive genetic model: CC vs (GC +GG), dominant genetic model: (GC+CC) vs GG
###end p 34
###begin p 35
###xml 0 12 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#167;</sup>
section signRyk's study was not involved in 16 studies.
###end p 35
###begin p 36
###xml 0 229 0 229 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Meta-analysis for NBS1 E185Q polymorphism variant genotypes (GC and CC) vs GG in different type of cancers (breast cancer, lung cancer, bladder cancer, basal cell carcinoma, ovarian cancer, prostate cancer, and colorectal cancer)</bold>
Meta-analysis for NBS1 E185Q polymorphism variant genotypes (GC and CC) vs GG in different type of cancers (breast cancer, lung cancer, bladder cancer, basal cell carcinoma, ovarian cancer, prostate cancer, and colorectal cancer).
###end p 36
###begin p 37
###xml 0 146 0 146 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Meta-analysis for NBS1 E185Q polymorphism variant genotypes (GC and CC) vs GG in different ethnicities (Caucasians, Chinese and African Americans)</bold>
Meta-analysis for NBS1 E185Q polymorphism variant genotypes (GC and CC) vs GG in different ethnicities (Caucasians, Chinese and African Americans).
###end p 37
###begin title 38
Quantitative data synthesis
###end title 38
###begin p 39
###xml 8 13 8 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NSB1 </italic>
###xml 257 260 257 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs </italic>
###xml 278 281 278 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs </italic>
###xml 304 307 304 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs </italic>
###xml 414 415 414 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 622 627 622 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GC/CC</italic>
###xml 690 692 690 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 992 994 992 994 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1074 1076 1074 1076 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1086 1088 1086 1088 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1134 1139 1134 1139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NSB1 </italic>
###xml 1228 1231 1228 1231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs </italic>
###xml 1267 1269 1267 1269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1316 1319 1316 1319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs </italic>
###xml 1360 1362 1360 1362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
For the NSB1 E185Q polymorphism, the data available for our meta-analysis were obtained from 17 datasets consisted of 9,734 cases and 10,325 controls. Associations of the NBS1 E185Q allele and genotypes with cancer risk were estimated using dominant (GC+CC vs GG), additive (CC vs GG), and recessive (CC vs GC +GG) genetic models in either fixed or random effect models according the heterogeneity Q test in Table 2. There were 16 datasets in these comparisons, except for Ryk's study that only showed data in dominant genetic models. Compared with the wild-type 8360 GG genotype, the carriers of variant genotypes (i.e., GC/CC) had a 1.06-fold elevated risk of cancer (95% CI = 1.00-1.12, P = 0.05) as estimated in a fixed effect model for dominant genetic effects. We further performed a sensitivity analysis, and found that when Hebbring's study was excluded owing to the conflict of Hardy-Weinberg equilibrium, the combined ORs of cancer risk was still 1.06 (95% CI = 1.00-1.12), and the P value of the between-study heterogeneity test was decreased significantly (from P = 0.54 to P = 0.48). However, the association between the NSB1 E185Q polymorphism and cancer risk was not significant in the additive genetic model (CC vs GG) (OR = 0.98, 95% CI = 0.85-1.13, P = 0.78) nor in the recessive genetic model (CC vs GC + GG) (OR = 0.94, 95% CI = 0.82-1.07, P = 0.36).
###end p 39
###begin p 40
###xml 330 332 330 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 385 386 385 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 583 585 583 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 601 602 601 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 718 720 718 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 831 833 831 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 849 850 849 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
The effect of 8360G>C (E185Q) polymorphism was further evaluated in stratification analysis. By the types of cancer, in those three lung cancer studies consisted of 605 cases and 639 controls, the variant genotypes (387 cases and 395 controls) had a non-significantly increased risk of lung cancer (OR = 1.08, 95% CI = 0.85-1.37, P = 0.54) as estimated in a fixed effect model (Figure 1). In the six breast cancer studies of 4,595 cases and 3,603 controls, the variant genotypes (2,490 cases and 1,902 controls) had a non-significantly increased risk (OR = 1.06, 95% CI = 0.97-1.16, P = 0.18) (Figure 1). Similarly, in the three bladder cancer studies of 1,446 cases and 1,452 controls (OR = 1.13, 95% CI = 0.98-1.31, P = 0.10) and three basal cell carcinoma studies of 770 cases and 1,107 controls (OR = 1.11, 95% CI = 0.92-1.35, P = 0.27) (Figure 1).
###end p 40
###begin p 41
###xml 201 203 201 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 263 265 263 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 330 332 330 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 348 349 348 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
In the stratification analyses for ethnicity, we found that the increased risk of cancer associated with 8360G>C variant genotypes was more pronounced in the Caucasians (OR = 1.07, 95% CI = 1.01-1.14, P = 0.03), but not in Chinese (OR = 0.84, 95% CI = 0.61-1.16, P = 0.30) nor in African Americans (OR = 1.05, 95% CI = 0.86-1.30, P = 0.62) (Figure 2).
###end p 41
###begin title 42
Bias diagnostics
###end title 42
###begin p 43
###xml 36 41 36 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NSB1 </italic>
###xml 239 241 239 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
###xml 258 260 258 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 336 341 336 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NSB1 </italic>
###xml 592 597 592 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NSB1 </italic>
###xml 640 641 640 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
To evaluate publication biases, the NSB1 E185Q genotypes were plotted against the precision ones in a funnel plot, which is approximately symmetrical. Egger's test suggested that there was no publication bias in the current meta-analysis (t = 0.15, df = 16, P = 0.88). Furthermore, we found that the fail-safe number for the finding of NSB1 E185Q variant genotypes associated with 1.06 fold increased risk of cancer was 60, which suggests that biases from publications and other factors may not have a significant influence on the results of current meta-analysis for the association between NSB1 E185Q polymorphism and cancer risk (Figure 3).
###end p 43
###begin p 44
###xml 0 78 0 78 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Funnel plot of the Egger's test of NBS1E185Q polymorphism for publication bias</bold>
Funnel plot of the Egger's test of NBS1E185Q polymorphism for publication bias.
###end p 44
###begin title 45
Discussion
###end title 45
###begin p 46
###xml 119 124 119 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NBS1 </italic>
In this meta-analysis consisted of 16 independent case-control studies with 17 datasets, we found that the carriers of NBS1 E185Q variant genotypes had a 1.06-fold increased risk of cancer in the dominant genetic model, and the association was more pronounced in the Caucasians. However, we did not find evidence for significant associations in the subgroup analysis for the individual type of cancers, such as lung cancer, breast cancer, basal cell carcinoma, urogenital cancers (i.e., bladder cancer, ovarian cancer, and prostate cancer), or colorectal cancer.
###end p 46
###begin p 47
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NBS1 </italic>
###xml 255 257 255 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 455 460 455 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NBS1 </italic>
###xml 461 462 461 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 704 706 704 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
The NBS1 8360G>C (rs1805794) polymorphism is a non-synonymous SNP with an amino acid change (Glu185>Gln or E185Q). Either one or two missense changes in the dominant genetic model may affect the function of NBS1 and interfere protein-protein interaction [50]. The E185Q amino acid substitution was predicted to be tolerated via the SIFT prediction tool . The E185Q SNP is located in a breast cancer carboxy-terminal (BRCT) domain (108-196 amino acids) of NBS1 [3], and such a domain facilitates NBS1 to interact with BRCA1 (one of two familial breast cancers mutated genes) forming BRCA1-associated genome surveillance complex (BASC), which is responsible for the recognition and repair of aberrant DNA [51].
###end p 47
###begin p 48
###xml 82 83 82 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 83 85 83 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 133 138 133 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NBS1 </italic>
###xml 196 204 196 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Leu34Leu</italic>
###xml 231 240 231 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pro672Pro</italic>
###xml 254 256 254 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 523 527 523 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT1 </italic>
###xml 528 530 528 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 805 806 805 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 806 808 806 808 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 897 902 897 902 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NBS1 </italic>
In the LD analysis, we found that the E185Q SNP was in a completed LD (D' = 1.00, r2 = 1.00) with the loci 626G>A in the promoter of NBS1 (-1418 nt to initiation transcription code ATG), 3816G>A (Leu34Leu, rs1063045) and 40419A>G (Pro672Pro, rs1061302) [21]. In further bioinformatics analysis searching for the transcription factor binding sites with the TFSEARCH program , we found that the 626G allele, but not the 626A allele, creates a new binding site of SRY that is a functional target of the tumor suppression gene WT1 [52], and that the 626G allele in LD with Glu185 may function in prohibiting carcinogenesis. Furthermore, in a region from 35309 bp upstream to 29477 bp downstream of E185Q on chromosome 8, we found that there were thirty-three polymorphisms being in completely LD (all with an r2 = 1.00) with E185Q (data not shown). Because the exact molecular mechanism involving the NBS1 E185Q variant in the etiology of cancer is still unclear, further investigations are needed to identify its LD with other unknown functional variants of cancer susceptibility candidate genes.
###end p 48
###begin p 49
###xml 185 190 185 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NBS1 </italic>
###xml 320 322 320 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 427 429 427 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 567 569 567 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 570 572 570 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 717 719 717 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 841 842 841 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 931 933 931 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1018 1020 1018 1020 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 1098 1100 1098 1100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1107 1112 1107 1112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NBS1 </italic>
###xml 1141 1146 1141 1146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GC/CC</italic>
###xml 1183 1187 1183 1187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53 </italic>
###xml 1254 1256 1254 1256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 1291 1297 1291 1297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC3 </italic>
###xml 1313 1318 1313 1318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NBS1 </italic>
###xml 1360 1362 1360 1362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
###xml 1398 1403 1398 1403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NBS1 </italic>
###xml 12 17 <span type="species:ncbi:9606">human</span>
###xml 627 632 <span type="species:ncbi:9606">human</span>
DNA DSBs in human cells is one of the major factors for carcinogenesis. Affected individuals when exposed to different carcinogens will have different outcomes. For example, the common NBS1 185Gln allele has been associated with an increased risk for lung cancer in a Chinese population exposed to smoky coal emissions [18]. Stable covalent BaP DNA adducts can cause single-strand breaks, resulting in DSBs during replication [53]. The established risk factors for bladder cancer include cigarette smoking, exposure to industrially related aromatic amines and drugs [54,55]. Some common, low-penetrance susceptibility genes in human populations may interact with radiation exposure to increase risk of breast cancer [56], because DNA DSBs are frequently induced by ionizing radiation, which may result in altered apoptosis or tumorigenesis [1]. For ovarian cancer, however, ovulation may play a role in ovarian cancer development [13]. Smoking and drinking habit are frequently associated with colorectal cancer risk [57]. BCCs are caused by interplay between genetic and environment factors, too [17]. The NBS1 E185Q variant genotypes (8360GC/CC) were found to be associated with a p53 mutation in lung cancer, suggesting a role in lung carcinogenesis [32]. Other report suggested that the XRCC3 interacted with NBS1 involved in the homologous recombination [58]. Therefore, it is likely that the NBS1 E185Q polymorphism may modify cancer susceptibility via gene-environment and gene-gene interactions. However, not all studies offer the information about environmental exposure.
###end p 49
###begin p 50
###xml 205 207 203 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 273 275 271 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 399 401 397 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B60">60</xref>
###xml 402 404 400 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B61">61</xref>
###xml 435 440 433 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NBS1 </italic>
###xml 198 203 <span type="species:ncbi:9606">women</span>
###xml 227 235 <span type="species:ncbi:9606">patients</span>
Sensitivity analysis showed that for breast cancer no association (combined OR = 1.05, 95% CI = 0.99-1.11) was present after exclusion of the study of Lu. In Lu's study the subjects were </= 55 old women [21]. About 40% of NBS patients develop cancer before the age of 21 [59]. It has been suggested that there are different etiologic pathways for early-onset and late-onset types of breast cancer [60,61]. Therefore, large studies of NBS1 E185Q stratified by age are needed to investigate the inter-individual susceptibility to cancer.
###end p 50
###begin p 51
There appeared to be ethnicity-specific genetic effects, because we found that the association between 8360G>C variant genotypes and increased risk of cancer was significant only in Caucasians but not in Chinese or African-Americans, suggesting genetic diversity among different ethnicities. The frequencies of 8360 C allele in the controls of selected studies were not as similar as that from the database of the International HapMap Project. We would take that into account when applying to the findings from the meta-analysis.
###end p 51
###begin p 52
Potential publication bias may exist in this meta-analysis, because the studies with negative results are more likely not to be published, though there was no testable publication bias in our meta-analysis by the funnel plot. Because there were only four out of 17 datasets were population-based case-control studies, others being hospital-based case-control studies, the study subjects may not be representative of the general population and could lead to selection bias.
###end p 52
###begin title 53
Conclusion
###end title 53
###begin p 54
###xml 80 85 80 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NBS1 </italic>
###xml 115 120 115 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GC/CC</italic>
In conclusion, our meta-analysis suggests that based on the published data, the NBS1 E185Q variant genotypes (8360 GC/CC) might be associated with an increased risk of cancer, especially in Caucasians. Due to the limitations of such meta-analysis, larger association studies or multicentric case-control studies and the studies assessing gene-environment interactions are warranted to confirm these findings.
###end p 54
###begin title 55
Abbreviations
###end title 55
###begin p 56
###xml 0 3 0 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink">NBS</bold>
###xml 31 35 31 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NBS1</italic>
###xml 31 35 31 35 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>NBS1</italic></bold>
###xml 76 80 76 80 <bold xmlns:xlink="http://www.w3.org/1999/xlink">DSBs</bold>
###xml 108 111 108 111 <bold xmlns:xlink="http://www.w3.org/1999/xlink">SNP</bold>
###xml 145 147 145 147 <bold xmlns:xlink="http://www.w3.org/1999/xlink">OR</bold>
###xml 161 163 161 163 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CI</bold>
NBS: Nijimegen break syndrome; NBS1: Nijimegen break syndrome mutated gene; DSBs: DNA double strand breaks; SNP: single nucleotide polymorphism; OR: odds ratio; CI: confidence interval.
###end p 56
###begin title 57
Competing interests
###end title 57
###begin p 58
The authors declare that they have no competing interests.
###end p 58
###begin title 59
Authors' contributions
###end title 59
###begin p 60
ML participated in study design and drafted the manuscript. JL carried out Bioinformatics Analysis and critically revised the manuscript. XY, MY, and HT performed the statistical analysis and participated in the critical revision of the manuscript. BY participated in collection of data and manuscript preparation. LS participated in its design. All authors read and approved the final manuscript.
###end p 60
###begin title 61
Pre-publication history
###end title 61
###begin p 62
The pre-publication history for this paper can be accessed here:
###end p 62
###begin p 63

###end p 63
###begin title 64
Acknowledgements
###end title 64
###begin p 65
The authors thank Xiuquan Shi, Pei Wang and Wei Gao for technical assistance, and Prof. Qingyi Wei (Department of Epidemiology, The University Texas MD Anderson Cancer Center, Houston, TX) for Science editing. This work was supported in part by the National Natural Scientific Foundation of China grants 3050416 (M. Lu), 30671813 and 30872178 (J. Lu).
###end p 65
###begin article-title 66
Variants in DNA double-strand break repair genes and breast cancer susceptibility
###end article-title 66
###begin article-title 67
Nijmegen breakage syndrome and DNA double strand break repair by NBS1 complex
###end article-title 67
###begin article-title 68
Molecular mechanism of the recruitment of NBS1/hMRE11/hRAD50 complex to DNA double-strand breaks: NBS1 binds to gamma-H2AX through FHA/BRCT domain
###end article-title 68
###begin article-title 69
Importin KPNA2 is required for proper nuclear localization and multiple functions of NBS1
###end article-title 69
###begin article-title 70
Nijmegen breakage syndrome gene, NBS1, and molecular links to factors for genome stability
###end article-title 70
###begin article-title 71
###xml 81 89 <span type="species:ncbi:9606">patients</span>
Impaired DNA double strand break repair in cells from Nijmegen breakage syndrome patients
###end article-title 71
###begin article-title 72
Nijmegen breakage syndrome: consequences of defective DNA double strand break repair
###end article-title 72
###begin article-title 73
Nijmegen breakage syndrome: clinical manifestation of defective response to DNA double-strand breaks
###end article-title 73
###begin article-title 74
Positional cloning of the gene for Nijmegen breakage syndrome
###end article-title 74
###begin article-title 75
The hMre11/hRad50 protein complex and Nijmegen breakage syndrome: linkage of double-strand break repair to the cellular DNA damage response
###end article-title 75
###begin article-title 76
Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome
###end article-title 76
###begin article-title 77
###xml 46 54 <span type="species:ncbi:9606">patients</span>
Germline 657del5 mutation in the NBS1 gene in patients with malignant melanoma of the skin
###end article-title 77
###begin article-title 78
Polymorphisms in DNA repair genes and epithelial ovarian cancer risk
###end article-title 78
###begin article-title 79
Mutations and molecular variants of the NBS1 gene in non-Hodgkin lymphoma
###end article-title 79
###begin article-title 80
NBS1 657del5 mutation may contribute only to a limited fraction of breast cancer cases in Russia
###end article-title 80
###begin article-title 81
Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer
###end article-title 81
###begin article-title 82
Basal cell carcinoma and variants in genes coding for immune response, DNA repair, folate and iron metabolism
###end article-title 82
###begin article-title 83
Smoky coal exposure, NBS1 polymorphisms, p53 protein accumulation, and lung cancer risk in Xuan Wei, China
###end article-title 83
###begin article-title 84
Increased cancer risk of heterozygotes with NBS1 germline mutations in Poland
###end article-title 84
###begin article-title 85
Single nucleotide polymorphisms in breast cancer
###end article-title 85
###begin article-title 86
###xml 119 124 <span type="species:ncbi:9606">women</span>
Polymorphisms and haplotypes of the NBS1 gene are associated with risk of sporadic breast cancer in non-Hispanic white women <or = 55 years
###end article-title 86
###begin article-title 87
ssSNPer: identifying statistically similar SNPs to aid interpretation of genetic association studies
###end article-title 87
###begin article-title 88
On estimating the relation between blood group and disease
###end article-title 88
###begin article-title 89
Quantitative synthesis in systematic reviews
###end article-title 89
###begin article-title 90
Bias in meta-analysis detected by a simple, graphical test
###end article-title 90
###begin article-title 91
###xml 76 84 <span type="species:ncbi:9606">patients</span>
Mutation analysis of the Nijmegen breakage syndrome gene (NBS1) in nineteen patients with acute myeloid leukemia with complex karyotypes
###end article-title 91
###begin article-title 92
Influence of polymorphisms in xenobiotic-metabolizing genes and DNA-repair genes on diepoxybutane-induced SCE frequency
###end article-title 92
###begin article-title 93
Breast cancer risk is associated with the genes encoding the DNA double-strand break repair Mre11/Rad50/Nbs1 complex
###end article-title 93
###begin article-title 94
###xml 165 173 <span type="species:ncbi:9606">patients</span>
Genetic polymorphisms in the DNA double-strand break repair genes XRCC3, XRCC2, and NBS1 are not associated with acute side effects of radiotherapy in breast cancer patients
###end article-title 94
###begin article-title 95
Global gene expression as a function of germline genetic variation
###end article-title 95
###begin article-title 96
###xml 72 80 <span type="species:ncbi:9606">patients</span>
Screening of homologous recombination gene polymorphisms in lung cancer patients reveals an association of the NBS1-185Gln variant and p53 gene mutations
###end article-title 96
###begin article-title 97
###xml 90 95 <span type="species:ncbi:9606">human</span>
Nijmegen breakage syndrome gene (NBS1) alterations and its protein (nibrin) expression in human ovarian tumours
###end article-title 97
###begin article-title 98
Effect of germ-line genetic variation on breast cancer survival in a population-based study
###end article-title 98
###begin article-title 99
###xml 67 75 <span type="species:ncbi:9606">patients</span>
Absence of mutations in the NBS1 gene in B-cell malignant lymphoma patients
###end article-title 99
###begin article-title 100
Increased risk of larynx cancer in heterozygous carriers of the I171V mutation of the NBS1 gene
###end article-title 100
###begin article-title 101
Polymorphism in nucleotide excision repair gene XPC correlates with bleomycin-induced chromosomal aberrations
###end article-title 101
###begin article-title 102
###xml 54 62 <span type="species:ncbi:9606">patients</span>
Molecular genetic analysis of NBS1 in German melanoma patients
###end article-title 102
###begin article-title 103
Characterization of the linkage disequilibrium structure and identification of tagging-SNPs in five DNA repair genes
###end article-title 103
###begin article-title 104
Polymorphisms in genes involved in DNA double-strand break repair pathway and susceptibility to benzene-induced hematotoxicity
###end article-title 104
###begin article-title 105
Polymorphisms in DNA repair genes, medical exposure to ionizing radiation, and breast cancer risk
###end article-title 105
###begin article-title 106
###xml 70 78 <span type="species:ncbi:9606">patients</span>
Single nucleotide polymorphisms for DNA repair genes in breast cancer patients
###end article-title 106
###begin article-title 107
Polymorphisms in the DNA repair genes XRCC1, APEX1, XRCC3 and NBS1, and the risk for lung cancer in never- and ever-smokers
###end article-title 107
###begin article-title 108
Polymorphisms of DNA repair genes and risk of non-small cell lung cancer
###end article-title 108
###begin article-title 109
Polymorphisms in DNA repair and metabolic genes in bladder cancer
###end article-title 109
###begin article-title 110
Single nucleotide polymorphisms in DNA repair genes and basal cell carcinoma of skin
###end article-title 110
###begin article-title 111
Role of the Nijmegen breakage syndrome 1 gene in familial and sporadic prostate cancer
###end article-title 111
###begin article-title 112
Evaluation of genetic variation in the double-strand break repair pathway and bladder cancer risk
###end article-title 112
###begin article-title 113
DNA repair genetic polymorphisms and risk of colorectal cancer in the Czech Republic
###end article-title 113
###begin article-title 114
Positional cloning and functional analysis of the gene responsible for Nijmegen breakage syndrome
###end article-title 114
###begin article-title 115
BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures
###end article-title 115
###begin article-title 116
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human sex-determining gene SRY is a direct target of WT1
###end article-title 116
###begin article-title 117
Genome maintenance mechanisms for preventing cancer
###end article-title 117
###begin article-title 118
Acetaminophen, some other drugs, some diseases and the risk of transitional cell carcinoma. A population-based case-control study
###end article-title 118
###begin article-title 119
Pooled analysis and meta-analysis of the glutathione S-transferase P1 Ile 105Val polymorphism and bladder cancer: a HuGE-GSEC review
###end article-title 119
###begin article-title 120
Radiation and breast cancer: a review of current evidence
###end article-title 120
###begin article-title 121
Alcohol drinking, cigarette smoking, and risk of colorectal adenomatous and hyperplastic polyps
###end article-title 121
###begin article-title 122
Xrcc3 is recruited to DNA double strand breaks early and independent of Rad51
###end article-title 122
###begin article-title 123
Nijmegen breakage syndrome. The International Nijmegen Breakage Syndrome Study Group
###end article-title 123
###begin article-title 124
Estimating age-specific breast cancer risks: a descriptive tool to identify age interactions
###end article-title 124
###begin article-title 125
Qualitative age interactions (or effect modification) suggest different cancer pathways for early-onset and late-onset breast cancers
###end article-title 125

